Imexpharm Corporation (HOSE:IMP)
Vietnam
· Delayed Price · Currency is VND 50,200
+100 (0.20%)
At close: Dec 5, 2025
Imexpharm Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,731,250 | 7,238,421 | 3,962,167 | 4,013,628 | 5,187,048 | 3,753,609 | Upgrade
|
| Market Cap Growth | 20.10% | 82.69% | -1.28% | -22.62% | 38.19% | 58.34% | Upgrade
|
| Enterprise Value | 7,708,450 | 7,072,195 | 3,840,834 | 3,828,514 | 5,172,206 | 3,829,402 | Upgrade
|
| Last Close Price | 50200.00 | 46549.81 | 25168.19 | 25127.46 | 31748.83 | 22544.27 | Upgrade
|
| PE Ratio | 23.21 | 24.33 | 14.26 | 21.83 | 29.89 | 20.89 | Upgrade
|
| Forward PE | 22.94 | 19.33 | 19.33 | 19.33 | 19.33 | 19.33 | Upgrade
|
| PS Ratio | 3.15 | 3.28 | 1.99 | 2.44 | 4.10 | 2.74 | Upgrade
|
| PB Ratio | 3.52 | 3.32 | 1.90 | 2.12 | 2.89 | 2.17 | Upgrade
|
| P/TBV Ratio | 3.64 | 3.43 | 1.97 | 2.20 | 3.01 | 2.27 | Upgrade
|
| P/FCF Ratio | - | 60.57 | - | 14.37 | 28.50 | - | Upgrade
|
| P/OCF Ratio | - | 33.47 | - | 10.60 | 22.08 | 51.31 | Upgrade
|
| EV/Sales Ratio | 3.14 | 3.21 | 1.93 | 2.33 | 4.08 | 2.80 | Upgrade
|
| EV/EBITDA Ratio | 13.30 | 13.62 | 8.28 | 10.73 | 17.56 | 12.12 | Upgrade
|
| EV/EBIT Ratio | 16.14 | 17.04 | 10.08 | 12.91 | 22.10 | 14.59 | Upgrade
|
| EV/FCF Ratio | -87.58 | 59.18 | - | 13.71 | 28.42 | - | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.04 | 0.02 | 0.05 | 0.15 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.64 | 0.17 | 0.11 | 0.27 | 0.90 | 0.41 | Upgrade
|
| Debt / FCF Ratio | - | 0.72 | - | 0.34 | 1.45 | - | Upgrade
|
| Asset Turnover | 0.88 | 0.90 | 0.85 | 0.72 | 0.58 | 0.69 | Upgrade
|
| Inventory Turnover | 1.72 | 1.68 | 1.78 | 1.78 | 1.46 | 1.94 | Upgrade
|
| Quick Ratio | 1.44 | 2.00 | 1.49 | 1.62 | 1.56 | 1.43 | Upgrade
|
| Current Ratio | 2.81 | 4.38 | 3.92 | 2.89 | 2.88 | 2.83 | Upgrade
|
| Return on Equity (ROE) | 16.66% | 15.04% | 15.06% | 12.12% | 10.73% | 12.75% | Upgrade
|
| Return on Assets (ROA) | 10.76% | 10.60% | 10.20% | 8.11% | 6.66% | 8.32% | Upgrade
|
| Return on Capital (ROIC) | 12.37% | 11.79% | 11.55% | 9.16% | 7.46% | 9.49% | Upgrade
|
| Return on Capital Employed (ROCE) | 20.10% | 19.00% | 18.30% | 15.70% | 12.40% | 15.00% | Upgrade
|
| Earnings Yield | 4.31% | 4.43% | 7.56% | 5.57% | 3.65% | 5.59% | Upgrade
|
| FCF Yield | -1.14% | 1.65% | -2.60% | 6.96% | 3.51% | -0.44% | Upgrade
|
| Dividend Yield | 1.00% | 1.07% | 1.81% | 1.72% | 2.04% | 2.88% | Upgrade
|
| Payout Ratio | 23.12% | 21.82% | 22.26% | 44.74% | 52.89% | 23.55% | Upgrade
|
| Buyback Yield / Dilution | - | - | 0.00% | 0.00% | -2.92% | -0.86% | Upgrade
|
| Total Shareholder Return | 1.00% | 1.07% | 1.81% | 1.72% | -0.87% | 2.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.